Neurosciences Research Program

Medicine & Life Sciences

1. Amyotrophic Lateral Sclerosis 100%
2. Brain 57%
3. Eye 57%
4. Parkinson Disease 56%
5. Stroke 52%
6. Alzheimer Disease 47%
7. Motor Neurons 44%
8. Ophthalmology 37%
9. Magnetic Resonance Imaging 36%
10. Therapeutics 35%
11. Neuroimaging 32%
12. Intracranial Aneurysm 32%
13. Vascular Dementia 31%
14. Aneurysm 30%
15. Papilledema 29%
16. Dementia 26%
17. Optic Nerve 26%
18. Ocular Vision 25%
19. Cognitive Dysfunction 25%
20. Pseudotumor Cerebri 25%
21. Optic Nerve Diseases 24%
22. Subarachnoid Hemorrhage 23%
23. Spinal Cord 23%
24. Giant Cell Arteritis 23%
25. Spinal Cord Injuries 22%
26. Glioblastoma 22%
27. DNA Glycosylases 22%
28. Pallidotomy 21%
29. DNA Repair 21%
30. Positron-Emission Tomography 20%
31. Myotonic Dystrophy 20%
32. Wounds and Injuries 20%
33. Blood Vessels 19%
34. Diplopia 19%
35. Single-Photon Emission-Computed Tomography 18%
36. Craniocerebral Trauma 18%
37. Muscles 17%
38. White Matter 17%
39. Myasthenia Gravis 17%
40. Cerebrospinal Fluid 17%
41. Cholinergic Receptors 17%
42. Cerebrovascular Circulation 17%
43. Spinocerebellar Ataxia 10 17%
44. Ophthalmoplegia 17%
45. Proteins 17%
46. Nervous System 17%
47. Neoplasms 16%
48. Neurodegenerative Diseases 16%
49. Clinical Trials 16%
50. Intracranial Pressure 16%
51. Amyloid 16%
52. Tomography 16%
53. Amyotrophic lateral sclerosis 1 15%
54. Disease Progression 15%
55. Spinocerebellar Ataxias 15%
56. Ophthalmologists 15%
57. Seizures 15%
58. Neurons 15%
59. Space Flight 15%
60. Mutation 15%
61. Ischemic Optic Neuropathy 14%
62. Microglia 14%
63. Visual Fields 14%
64. Genes 14%
65. Neurology 14%
66. Pathology 14%
67. Skeletal Muscle 13%
68. Membranes 13%
69. DNA 13%
70. Placebos 13%
71. Glioma 13%
72. Abducens Nerve Diseases 13%
73. Antibodies 13%
74. Ataxia 13%
75. Intracranial Hypertension 13%
76. Tropical Spastic Paraparesis 13%
77. Muscular Dystrophies 13%
78. (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine 12%
79. Nervous System Diseases 12%
80. Genome 12%
81. Central Nervous System 12%
82. Equipment and Supplies 12%
83. Population 12%
84. DNA Damage 12%
85. Oculomotor Nerve Diseases 12%
86. Stents 12%
87. Immunoglobulin G 12%
88. Infarction 12%
89. Headache 12%
90. Safety 12%
91. Multiple Sclerosis 12%
92. Cavernous Sinus 12%
93. Biopsy 11%
94. Brain Ischemia 11%
95. Head 11%
96. Elderly 11%
97. In Vitro Techniques 11%
98. Regulatory T-Lymphocytes 11%
99. Tremor 11%
100. Cholinergic Agents 11%